title: Cdad-Daysyms™: A New Patient-Reported Outcome Tool For Clostridium Difficile-Associated Diarrhoea.
authors.affiliation: Evidera, Seattle, WA, USA.
authors.forename: L
authors.initials: L
authors.lastname: Kleinman
authors.affiliation: Talbot Advisors LLC, Anna Maria, FL, USA.
authors.forename: G H
authors.initials: GH
authors.lastname: Talbot
authors.affiliation: Actelion Pharmaceuticals Ltd, Allschwil, Switzerland.
authors.forename: R
authors.initials: R
authors.lastname: Schüler
authors.affiliation: Cubist Pharmaceuticals, Lexington, MA, USA.
authors.forename: K
authors.initials: K
authors.lastname: Broderick
authors.affiliation: Evidera, Bethesda, MD, USA.
authors.forename: D
authors.initials: D
authors.lastname: Revicki
authors.affiliation: Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
authors.forename: C E
authors.initials: CE
authors.lastname: Nord